Related Experiment Video
Updated: Jun 10, 2025

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Smooth Muscle Surprise: Documenting a Primary Ovarian Leiomyosarcoma Case
Vallal Kani1, Sumithra Arumugam1, Karthika Rajendran1
1Department of Pathology, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technnical Sciences, Saveetha University, Chennai, IND.
Primary ovarian leiomyosarcoma (LMS) is a rare, aggressive ovarian cancer. This case report details a 66-year-old woman diagnosed with advanced LMS, highlighting diagnostic challenges and poor prognosis.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Medical Oncology
Background:
- Primary ovarian leiomyosarcoma (LMS) is an exceptionally rare and aggressive malignancy originating from ovarian smooth muscle tissue.
- This tumor predominantly affects postmenopausal women and is often diagnosed at advanced stages, presenting a significant challenge due to its poor prognosis.
Observation:
- A 66-year-old woman presented with persistent lower abdominal pain, weight loss, and anorexia.
- Imaging revealed a large, heterogeneous solid left adnexal mass, indicative of a malignant ovarian neoplasm.
- Histopathological analysis confirmed high-grade spindle cell sarcoma, consistent with ovarian LMS, with immunohistochemistry supporting smooth muscle differentiation.
Findings:
- The patient underwent surgery and initiated chemotherapy but was lost to follow-up.
- The rarity of ovarian LMS limits understanding of adjuvant chemotherapy and radiotherapy efficacy.
- Diagnosis is challenging, and treatment options are scarce, contributing to a poor patient outlook.
Implications:
- This case underscores the diagnostic difficulties and limited therapeutic strategies for primary ovarian LMS.
- The lack of established standard treatments necessitates further research into effective therapeutic interventions for this aggressive cancer.
- Developing novel treatment approaches is crucial to improve outcomes for patients diagnosed with ovarian LMS.
More Related Videos
08:17Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
05:42Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024